GC Cell Beheer
Beheer criteriumcontroles 0/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
James Park
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | no data |
Eigendom CEO | 0.1% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price
Oct 14Is GC Cell (KOSDAQ:144510) A Risky Investment?
Sep 08We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative
Mar 19We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt
Feb 22Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?
Jan 18Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?
Dec 14CEO
James Park (58 yo)
no data
Tenure
Mr. James Park is Chairman of the Board of BioCentriq, Inc and was its Interim CEO. He had been a Director of Artiva Biotherapeutics, Inc. since January 2023 until July 2024. He served as Executive VP at S...